methamphetamine has been researched along with rivastigmine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Culbertson, C; De La Garza, R; Mahoney, JJ; Newton, TF; Shoptaw, S | 1 |
| De La Garza, R; Newton, TF; Shoptaw, S | 1 |
| Croft, DE; De La Garza, R; Jaeggi, S; Kalechstein, AD; Mahoney, JJ; Yoon, JH | 1 |
| De la Garza, R; Yoon, JH | 1 |
| Aziziyeh, A; De La Garza, R; Haile, CN; Mahoney, JJ; Nerumalla, CS; Newton, TF; Yoon, JH | 1 |
1 review(s) available for methamphetamine and rivastigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for methamphetamine and rivastigmine
| Article | Year |
|---|---|
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Choice Behavior; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Methamphetamine; Middle Aged; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Self Administration; Substance Abuse, Intravenous | 2008 |
Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers.
Topics: Adolescent; Adult; Affect; Analysis of Variance; Blood Pressure; Cardiovascular System; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Evaluation Studies as Topic; Heart Rate; Human Experimentation; Humans; Male; Methamphetamine; Middle Aged; Neuroprotective Agents; Pain Measurement; Phenylcarbamates; Rivastigmine; Substance-Related Disorders; Time Factors | 2008 |
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Attention; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Time Factors; Young Adult | 2011 |
Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Humans; Methamphetamine; Middle Aged; Phenylcarbamates; Rivastigmine; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2011 |
Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Phenylcarbamates; Rivastigmine | 2012 |
2 other study(ies) available for methamphetamine and rivastigmine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |